Navigation Links
Express Genes by Eurofins MWG Operon Offers 4 Day Delivery of Synthetic Genes
Date:3/20/2013

Huntsville, AL (PRWEB) March 20, 2013

Eurofins MWG Operon announces the newest entry in their drive to provide ISO-quality research products and services ‘faster than ever.’ Synthetic genes are a rapidly expanding area of business and clients are anxious to accelerate their research in this highly-competitive field of investigation. Customers throughout the US and Canada can now order the new Express Gene service as late as 3:00 p.m. ET for completion just 4 days later - a full day earlier than any advertised service from competitors.

“We’re excited to share our advances in gene synthesis services with our clients. Delivering Express Genes in just 4 days is faster than our competitors are able to advertise. Express Genes joins Overnight DNA sequencing (available for all US locations) and Express Oligos further extending our efforts to be the fastest DNA Company in the US,” stated Martin Kunz, CEO of Eurofins MWG Operon Inc. “The new Express Genes service benefits the research of any institution or company pursuing development in fast cycles.”

“Express Genes is an exciting new offering," stated Helaman Escobar, Director of DNA Sequencing Operations at Eurofins MWG Operon Inc. “Advances in the laboratory have shortened our process for creating high-quality synthetic genes, which includes full DNA sequencing confirmation of the construct. These advances, and production of all gene synthesis under ISO 9001/13485 specifications, make Express Genes a highly competitive entry into the fastest growing segment of the DNA marketplace.” Visit operon.com/express-gene for more information about Express Gene synthetic gene services.

About Eurofins MWG Operon
Eurofins MWG Operon, a member of the Eurofins Group with major offices and production facilities in the United States, Europe, and Asia, is an international provider of DNA sequencing services, DNA synthesis products, and bioinformatics services for academic and industrial research. The company’s strengths are its strong customer orientation, fast service, and high quality. For additional information, please visit our website at operon.com.

For further information, contact:

Donna Brown
Eurofins MWG Operon
2211 Seminole Drive
Huntsville, Alabama 35805
Phone: (256) 799-5890
Email: donnabrown(at)eurofins(dot)com

Read the full story at http://www.prweb.com/releases/2013/3/prweb10548945.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
2. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
3. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
4. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
5. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
6. HemoShear Partners with Expression Analysis (EA) to Develop a Human Drug-Induced Vascular Response Database
7. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
8. Exon skipping to restore gene expression is promising therapeutic strategy for muscular dystrophy
9. Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview
10. transOMIC technologies Releases Tagged ORF Clones for Protein Expression
11. Free Research Report on Dyax Corp., Ebix, Inc., 8x8, Inc., EnerSys and Express Scripts Holding Co.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published ... frozen and fresh in vitro fertilization (IVF) transfer cycles. The multi-center ... success. , After comparing the results from the fresh and frozen transfer cohorts, ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... DALLAS , Oct. 10, 2017 International research firm ... IoT Strategy, will speak at the TMA 2017 Annual Meeting , ... key trends in the residential home security market and how smart safety ... ... "The ...
Breaking Biology Technology:
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative ... ... Maldives Immigration ... Algeen (small picture on the right) have received the IAIR award for ...
Breaking Biology News(10 mins):